On April 19-20, 2023, partner Ben Greenblum will speak on a panel titled “Reverse-Payment Settlements: Demystifying the Current State of Pharmaceutical Litigation Settlements in the Hatch-Waxman Context” at the ACI Paragraph IV Disputes Conference in New York. This conference provides Hatch-Waxman lawyers with practical information on developments that affect both substantive and procedural matters of import for brand named and generics.
Ben has extensive experience in antitrust and other complex civil litigation. He is recognized as a leading member of the bar defending so-called “pay for delay” or “reverse payment” patent settlements from antitrust attack, serving as trial counsel in the only two such cases ever to go to jury verdict. With years of experience litigating such cases, Ben advises on all manner of antitrust issues arising from the Hatch-Waxman Act and food and drug law.
To learn more about this conference, click here.